MetriTrack
MetriTrack is a US medical device company that develops the FDA-cleared BVN G-2000, a sensor-based adjunct to handheld breast ultrasound that automates coverage tracking and sub-centimeter lesion mapping for breast imaging facilities serving women with dense breast tissue.
- Company typePrivate
- Founded2014
- HeadquartersHillside, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What MetriTrack does
MetriTrack, Inc. is a US-based, privately held medical device company founded in 2014 by breast radiologist Dr. Calin Caluser and headquartered in Oak Brook, Illinois. The company develops the BVN (Breast Volume Navigator) Model G-2000, an FDA 510(k)-cleared adjunct to handheld breast ultrasound that uses small sensors on the probe and patient skin, combined with proprietary dynamic mapping technology and anatomical referencing, to generate real-time 3D maps of the breast and axilla and localize lesions within a few millimeters. The system targets the clinical gap in dense-breast screening, where more than 60,000 detectable cancers are missed annually by mammography, by reducing inter-operator variability, automating coverage tracking, indexing lesions across exams, and enabling teleultrasound for remote expert support.
The BVN G-2000 is the company's sole commercial product and integrates with existing ultrasound machines and MIMPS (formerly PACS) systems. MetriTrack generates revenue primarily through hardware sales of the BVN G-2000 to breast imaging facilities, hospitals, and clinics, supplemented by ongoing installation, training, and support services delivered through its distribution and training partners. Go-to-market is executed via a mix of direct enterprise sales and US regional channel partners — Excel Imaging Solutions in the southeastern United States and SST Group in the Midwest, together with Mammography Educators for sonographer training.
MetriTrack has secured FDA 510(k) clearance (May 2021), ISO 13485:2016 certification (March 2022), Intertek electrical/EMC safety certification, and compliance with FDA 21 CFR 820. The technology is protected by multiple US and international patents and the registered BVN trademark. The company has raised approximately $2.075M in disclosed seed funding across 2018–2019 and an NIH SBIR Phase I grant; revenue, valuation, and current headcount figures are not publicly disclosed beyond an estimated 1–10 employees.
MetriTrack firmographics
Firmographics- Name
- MetriTrack
- Legal name
- MetriTrack, Inc.
- Website
- https://metritrack.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MetriTrack is a US medical device company that develops the FDA-cleared BVN G-2000, a sensor-based adjunct to handheld breast ultrasound that automates coverage tracking and sub-centimeter lesion mapping for breast imaging facilities serving women with dense breast tissue.
- Ownership category
- akta.pro rank
MetriTrack industry classification
Industry- Product category
- Breast Ultrasound Imaging Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Mammography & Breast Imaging Systems (HLAHABAF)
- akta.pro secondary industry
- Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL)
Keywords
Where MetriTrack is headquartered
LocationHeadquarters
- HQ city
- Hillside
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MetriTrack business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Others
Revenue model
- Medical Device Sales: Sale of BVN G-2000 Breast Volume Navigator system as FDA-cleared medical device. The system is available for purchase and installation at imaging facilities. Revenue generated from initial device sales to healthcare facilities including hospitals, breast centers, and imaging clinics.
- Medical Device Support Services: Ongoing support, training, and potentially service contracts associated with the medical device. Distribution partners provide installation and support services.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
MetriTrack product offering
Product offeringCore offering
MetriTrack develops and sells the BVN™ Model G-2000 (Breast Volume Navigator), an FDA-cleared medical device that serves as an adjunct to handheld ultrasound for breast cancer care. The system uses small sensors at the ultrasound probe and patient skin with proprietary dynamic mapping technology to generate real-time 3D breast and axilla maps, track whole-breast volume coverage, localize small lesions within a few millimeters, index lesions in ACR-recommended format, and enable TeleUltrasound remote expert support. It is sold as hardware to hospitals, breast centers and imaging clinics, with installation, training and support delivered through regional distributors and a dedicated training partner.
Product overview
MetriTrack offers a single unified core product — the BVN™ (Breast Volume Navigator) Model G-2000 system. This FDA-cleared device is an adjunct to existing handheld ultrasound systems that automates breast ultrasound throughout the breast cancer care continuum. The system uses proprietary sensors at the ultrasound probe and patient's skin with anatomical referencing technology to generate real-time 3D breast and axilla maps, provide precise lesion coordinates, ensure complete breast volume coverage, and enable TeleUltrasound remote expert communication. It is designed to work in conjunction with any quality handheld ultrasound system and MIMPS (formerly PACS) to improve the clinician's ability to navigate the breast, annotate lesions, track lesions across exams, and ensure completeness of coverage — all while replacing time-consuming manual steps with automated workflows.
Differentiator
Problem solved
Functional benefit
Products and services
- BVN Model G-2000 (Breast Volume Navigator) FDA-cleared (May 26, 2021) computer-assisted breast ultrasound system that serves as an adjunct to handheld ultrasound. It uses proprietary small sensors at the ultrasound probe and patient skin with dynamic 3D mapping technology to provide coverage mapping, precision lesion mapping accurate within a few millimeters, lesion indexing in ACR-recommended format, on-screen navigation guidance, automated graphic and numerical reports, and TeleUltrasound remote expert support. Designed for hospitals, breast centers, imaging clinics and radiology practices performing breast ultrasound for dense-breast screening, detection, biopsy guidance, treatment planning and monitoring.
Companies that use MetriTrack
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
MetriTrack technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature8 records
MetriTrack partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Mammography Educators LLCcoreWorldwide leading provider of mammography and breast ultrasound education services. Partnership launched custom sonographer training using MetriTrack's BVN G-2000 solution. Mammography Educators provides on-site and remote training for breast sonographers, enabling rapid expansion of breast ultrasound procedures. Tele-ultrasound capability enables breast radiologists to support sonographers remotely.
- SST Group Inc. (Storage Solutions Technology Group)coreDistribution partnership to bring BVN G-2000 to imaging clinics across the Midwest. SST Group is an innovative leader in DICOM image delivery and management, providing solutions to over 2500 hospitals and private clinics worldwide since 2004. SST Group distributes and supports the BVN-2000 into all segments of the radiology market for breast ultrasound imaging in Midwestern states.
- Excel Imaging SolutionscoreDistribution agreement for southeastern United States. Major distributor of radiology imaging equipment distributing and supporting the BVN G-2000 into all segments of the radiology market for breast ultrasound imaging. Presented BVN G-2000 at technology show in Coral Gables, FL in February 2023.
- Acibadem UniversityminorJoint submission to IHH Innovation Challenge Competition with project based on MetriTrack's technology. Acibadem University is one of the leading medical centers in Turkey. The collaboration won the prestigious IHH Innovation Challenge Competition in 2021.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
MetriTrack competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
MetriTrack compliance and trust
Trust signalCompliance4 records
MetriTrack financial estimates
Financial estimateRevenue estimate
Valuation estimate
MetriTrack leadership team
Management profileNumber of profiles
Profiles4 records
MetriTrack funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MetriTrack M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MetriTrack
What does MetriTrack do?
MetriTrack develops and sells the BVN™ Model G-2000 (Breast Volume Navigator), an FDA-cleared medical device that serves as an adjunct to handheld ultrasound for breast cancer care. The system uses small sensors at the ultrasound probe and patient skin with proprietary dynamic mapping technology to generate real-time 3D breast and axilla maps, track whole-breast volume coverage, localize small lesions within a few millimeters, index lesions in ACR-recommended format, and enable TeleUltrasound remote expert support. It is sold as hardware to hospitals, breast centers and imaging clinics, with installation, training and support delivered through regional distributors and a dedicated training partner.
Is MetriTrack a public or private company?
MetriTrack is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MetriTrack founded?
MetriTrack was founded in 2014. It employs 1 to 10 people.
Where is MetriTrack based?
MetriTrack is headquartered in Hillside, United States, in the North America region.
How does MetriTrack make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are medical Device Support Services.
Does MetriTrack have an API?
No public API is recorded for MetriTrack.
What industry is MetriTrack in?
MetriTrack's product category is Breast Ultrasound Imaging Devices. Its primary akta.pro industry code is HLAHABAF, Mammography & Breast Imaging Systems, with a secondary code of HLAHABAL, Portable, Mobile & Point-of-Care Imaging Systems. Its NAICS code is 334510 and its SIC code is 3845.